<SEC-DOCUMENT>0001650664-25-000081.txt : 20250514
<SEC-HEADER>0001650664-25-000081.hdr.sgml : 20250514
<ACCEPTANCE-DATETIME>20250514070656
ACCESSION NUMBER:		0001650664-25-000081
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250514
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250514
DATE AS OF CHANGE:		20250514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Editas Medicine, Inc.
		CENTRAL INDEX KEY:			0001650664
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				464097528
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37687
		FILM NUMBER:		25942603

	BUSINESS ADDRESS:	
		STREET 1:		11 HURLEY ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		617-401-9000

	MAIL ADDRESS:	
		STREET 1:		11 HURLEY ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>edit-20250514.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5a1307e5-6ae0-4445-b99b-68f1773def48,g:9b734371-2261-41f0-a0f0-9721f2b79a0e,d:f6e42a24ec764255ba9a158371fb6bae-->
<html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>edit-20250514</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001650664</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="edit-20250514.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001650664</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-14</xbrli:startDate><xbrli:endDate>2025-05-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if6e42a24ec764255ba9a158371fb6bae_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">of The Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May 14, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________________________________________</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Editas Medicine, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________________________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:39.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.223%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37687</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">46-4097528</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">11 Hurley Street</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Cambridge,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Massachusetts</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">02141</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">617</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">401-9000</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________________________________________________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">EDIT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if6e42a24ec764255ba9a158371fb6bae_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01&#160;&#160;&#160;&#160;Regulation FD Disclosure.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2025, Editas Medicine, Inc. (the &#8220;Company&#8221;) issued a press releases titled &#8220;Editas Medicine Reports New </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Data Highlighting the Potential of Editas&#8217; Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting,&#8221; a copy of which is furnished as Exhibit 99.1 hereto.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Item 7.01, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></div><div id="if6e42a24ec764255ba9a158371fb6bae_10"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01              Other Events.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2025, the Company announced new </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> data demonstrating therapeutically relevant levels of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HBG1/2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> promoter editing in hematopoietic stem cells (&#8220;HSCs&#8221;) with a single dose of proprietary targeted lipid nanoparticle (&#8220;tLNP&#8221;) in humanized mice and non-human primates (&#8220;NHPs&#8221;).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In these studies, the Company&#8217;s proprietary tLNP formulation delivered</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> HBG1/2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> promoter editing cargo to hematopoietic stem and progenitor cells and/or HSCs in humanized mice (mice engrafted with human CD34+ cells) and in NHPs. In an ongoing NHP study, administration of a single intravenous dose of the Company&#8217;s proprietary tLNP demonstrated high efficiency HSC delivery and achieved up to 47% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HBG1/2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> editing levels. In a study with humanized mice, administration of a single dose achieved 48% editing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HBG1/2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in long-term HSCs. Both studies exceeded the predicted editing threshold of &#8805;25% required for therapeutic benefit. In addition to achieving therapeutically relevant editing levels, preliminary biodistribution data in NHPs with the Company&#8217;s tLNP shows significant de-targeting of the liver in contrast to standard LNPs.</span></div><div id="if6e42a24ec764255ba9a158371fb6bae_13"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.204%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="editasmedicineasgctinvivoh.htm">Press release issued by the Company on May 14, 2025*</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="margin-top:12pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.5pt">This exhibit shall be deemed to be furnished and not filed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if6e42a24ec764255ba9a158371fb6bae_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.114%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EDITAS MEDICINE, INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 14, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Amy Parison</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amy Parison</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>editasmedicineasgctinvivoh.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i4ba7e0d6c32648b0ac967802bd2e4930_1"></div><div style="min-height:97.2pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:70px;margin-bottom:5pt;vertical-align:text-bottom;width:148px"></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Editas Medicine Reports New</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> In Vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> Data Highlighting the Potential of Editas&#8217; Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Data demonstrate therapeutically relevant editing levels using a clinically validated strategy, supporting its development as a novel, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> approach to treating sickle cell disease and beta thalassemia</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CAMBRIDGE, Mass., May 14, 2025 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8211; Editas Medicine, Inc. (Nasdaq&#58; EDIT), a pioneering gene editing company, today shared new </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">in vivo </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">data demonstrating therapeutically relevant levels of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">HBG1&#47;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> promoter editing in hematopoietic stem cells (HSCs) with a single dose of proprietary targeted lipid nanoparticle (tLNP) in humanized mice and non-human primates (NHPs). This clinically validated approach targeting </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">HBG1&#47;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> promoters to upregulate fetal hemoglobin (HbF) is in pre-clinical development as a potential transformative </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">in vivo </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">gene editing medicine for the treatment of sickle cell disease and beta thalassemia. The Company reported these data in a presentation available today and will detail the data in an oral presentation today at 1&#58;30 p.m. CT&#47;2&#58;30 p.m. ET at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) in New Orleans, LA, and virtually. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In these studies,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company&#8217;s proprietary </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">tLNP </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">formulation delivered </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">HBG1&#47;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> promoter editing cargo to HSPCs and&#47;or HSCs in humanized mice (mice engrafted with human CD34+ cells) and in NHPs.  In an ongoing NHP study, administration of a single intravenous dose of Editas Medicine&#8217;s proprietary tLNP demonstrated high efficiency HSC delivery and achieved up to 47% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">HBG1&#47;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> editing levels. In a study with humanized mice, administration of a single dose achieved 48% editing of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">HBG1&#47;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in long-term HSCs. Both studies exceeded the predicted editing threshold of &#8805;25% required for therapeutic benefit. In addition to achieving therapeutically relevant editing levels, preliminary biodistribution data in NHPs with Editas&#8217; tLNP shows significant de-targeting of the liver in contrast to standard LNPs. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;These findings are very encouraging and further support our approach to developing a potentially first- and best-in-class </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">in vivo </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">gene edited medicine for the treatment of sickle cell disease and beta thalassemia,&#8221; said Linda C. Burkly, Ph.D., Executive Vice President and Chief Scientific Officer, Editas Medicine. &#8220;We believe that translating these preclinical results to the clinic will address the continuing significant unmet need for a transformative gene edited medicine with the potential to improve the lives of people living with sickle cell disease and beta-thalassemia around the world.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Editas Medicine&#8217;s </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">in vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> HSC program targets </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">HBG1&#47;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> promoters to mimic naturally occurring mechanisms of hereditary persistence of fetal hemoglobin (HPFH) and utilizes proprietary </font></div><div style="height:113.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.2pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AsCas12a to edit with high efficiency and minimize off-target editing. Editing the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">HBG1&#47;2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">promoters with AsCas12a with the investigational medicine reni-cel led to robust increases in fetal hemoglobin (HbF) and total hemoglobin (Hb) in clinical trials.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Oral Presentation Details&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In Vivo</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Delivery of HBG1&#47;2 Promoter Editing Cargo to HSC of Humanized Mouse and Non-Human Primate with Lipid Nanoparticles</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Session Date and Time&#58;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Wednesday, May 14, 2025, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1&#58;30 p.m. &#8211; 1&#58;45 p.m. CT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> <br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Session Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;Translational Applications of Base and Prime Editors<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Room&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;265-268<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Final Abstract Number&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> AMA353</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Additional Editas Medicine presentations are below. Abstracts can be accessed on the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ASGCT website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and the presentations will be posted on the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Editas Medicine website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> during the conference.</font><font style="color:#525650;font-family:'Mona Sans',sans-serif;font-size:14.5pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Poster Presentations&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Design and Development of Improved LNP Targeting Ligands for </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In Vivo</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Hematopoietic Stem Cell Editing</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Session Date and Time&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tuesday, May 13, 2025, 6&#58;00 p.m. &#8211; 7&#58;30 p.m. CT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Session Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tuesday Poster Reception<br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Presentation Room&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;Poster Hall, Hall 12<br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Final Abstract Number&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AMA245<br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Design of Chemically Modified AsCas12a Guide RNAs for Increased Potency of LNP-Delivered Gene Editing Cargos</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Session Date and Time&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tuesday, May 13, 2025, 6&#58;00 p.m. &#8211; 7&#58;30 p.m. CT</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>Session Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tuesday Poster Reception<br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Presentation Room&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;Poster Hall, Hall 12<br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Final Abstract Number&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;AMA420</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In Vivo</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Gene Editing and Disease-Associated Biomarker Reduction for Multiple Liver Targets in Non-human Primate Using AsCas12a Nuclease Delivered by LNP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Session Date and Time&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Wednesday, May 14, 2025, 5&#58;30 p.m. &#8211; 7&#58;00 p.m. CT</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>Session Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Wednesday Poster Reception<br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Presentation Room&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;Poster Hall, Hall 12 <br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Final Abstract Number&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;AMA640<br></font></div><div style="height:113.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.2pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Title&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In Vivo</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> CRISPR Editing of Genetic Regulatory Regions Results in Functional Upregulation of Target Protein and Meaningful Reduction of Disease-Associated Biomarker in Mice</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Session Date and Time&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Wednesday, May 14, 2025, 5&#58;30 p.m. &#8211; 7&#58;00 p.m. CT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Session Title&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Wednesday Poster Reception<br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Presentation Room&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;Poster Hall, Hall 12 <br></font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Final Abstract Number&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;AMA351</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Editas Medicine</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As a pioneering gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR&#47;Cas12a and CRISPR&#47;Cas9 genome editing systems into a robust pipeline of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">in vivo </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">medicines for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">in vivo </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">gene editing medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute&#8217;s Cas12a patent estate and Broad Institute and Harvard University&#8217;s Cas9 patent estates for human medicines. For the latest information and scientific presentations, please visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.editasmedicine.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">###</font></div><div style="text-align:center"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Media and Investor Contact&#58;</font></div><div><font style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ir&#64;editasmed.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#160;</font></div><div><font><br></font></div><div style="height:113.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>edit-20250514.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5a1307e5-6ae0-4445-b99b-68f1773def48,g:9b734371-2261-41f0-a0f0-9721f2b79a0e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:edit="http://www.editasmedicine.com/20250514" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.editasmedicine.com/20250514">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="edit-20250514_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="edit-20250514_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="edit-20250514_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.editasmedicine.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>edit-20250514_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5a1307e5-6ae0-4445-b99b-68f1773def48,g:9b734371-2261-41f0-a0f0-9721f2b79a0e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.editasmedicine.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="edit-20250514.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.editasmedicine.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a37ad0f6-1059-4fab-b2e1-44d56c73c34c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4972ef3b-4705-4cd2-b37b-249a844cb6c6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_a37ad0f6-1059-4fab-b2e1-44d56c73c34c" xlink:to="loc_dei_DocumentInformationTable_4972ef3b-4705-4cd2-b37b-249a844cb6c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0a012402-3b6d-497d-bcc2-157d561f061b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a37ad0f6-1059-4fab-b2e1-44d56c73c34c" xlink:to="loc_dei_DocumentPeriodEndDate_0a012402-3b6d-497d-bcc2-157d561f061b" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>edit-20250514_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5a1307e5-6ae0-4445-b99b-68f1773def48,g:9b734371-2261-41f0-a0f0-9721f2b79a0e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentPeriodEndDate_9476191e-b976-4d29-a629-7eb3da8aeccf_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_7e1ea4f0-1218-4a42-be03-4c690dd7221d_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_3534de36-7f33-471c-b381-2c49d4dd94bf_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1b176fc1-e2a9-430c-addd-1048a50b0dca_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_19e79146-2d91-45bf-b960-70bfc45068f1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_26b81991-6b13-4ea8-be81-3a610d465677_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_86cc722f-de42-4b0a-b2f1-14c11861e986_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7f50fa6a-4399-472c-90b2-daf785405422_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bd244b8e-713e-413f-8004-3eb9a968be5b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_9e1fd972-d1b9-4e7b-a45f-4f64ed84e3a8_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_addd7c83-750b-4b4f-b5fb-3c1bbab05fa4_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ff6fcc82-a24b-46bb-bc6f-6049a67b93f0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f97fb1b7-9570-4c29-8911-bdadfc7a4ca9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d5f00fa1-9a66-4918-990b-80b7040612b9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ecf7f095-ff53-4dc7-9ec8-cda071b5819e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_120776fd-248e-4bf5-9558-27ff5d7a30aa_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_7bae039b-498d-4792-b240-fa5b83b5b6ba_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6c409a10-b0c3-4c12-9bd8-f36d91981728_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_bb1d5264-b167-4ff1-ad8f-62cdbb013354_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_66ebe809-3cd9-481f-bd50-64fc4882c95e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_561c533b-db86-44dc-83b6-b9462b60bc6a_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_17ef1b0c-b7b0-4852-bd88-518e62c4f850_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c5b5281f-de7c-421f-bb09-4e0b92e8500f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9ef18a3a-e4b3-43b8-be65-54da6474a8ad_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_aadd6442-ab0c-4553-b8d2-1d4f40728da5_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>edit-20250514_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:5a1307e5-6ae0-4445-b99b-68f1773def48,g:9b734371-2261-41f0-a0f0-9721f2b79a0e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.editasmedicine.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="edit-20250514.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.editasmedicine.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cd44bbb1-0b25-4eb2-84a4-8e764024a21b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_DocumentType_cd44bbb1-0b25-4eb2-84a4-8e764024a21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_75c6205a-eeee-43d2-a085-6a4a16ea20bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_DocumentPeriodEndDate_75c6205a-eeee-43d2-a085-6a4a16ea20bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bf4a2998-6209-4555-9a51-4f42678b82ed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityFileNumber_bf4a2998-6209-4555-9a51-4f42678b82ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8ef5ff56-aeed-4f65-b8f1-a78fb1a5bcbf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityRegistrantName_8ef5ff56-aeed-4f65-b8f1-a78fb1a5bcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_349f1a06-ef17-4c22-ade7-984dec59506c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_349f1a06-ef17-4c22-ade7-984dec59506c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4d97c569-1b58-4b70-9766-102a519620fd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityTaxIdentificationNumber_4d97c569-1b58-4b70-9766-102a519620fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8f584260-5587-4b6e-ac87-4cb8d2e03a3b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityAddressAddressLine1_8f584260-5587-4b6e-ac87-4cb8d2e03a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_986061c6-8dd0-462c-8fa7-94c3514b0d86" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityAddressCityOrTown_986061c6-8dd0-462c-8fa7-94c3514b0d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b8957fbb-433c-4b20-ac3d-7357ecd4abb3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityAddressStateOrProvince_b8957fbb-433c-4b20-ac3d-7357ecd4abb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9220f2ea-13f0-4b9f-912a-e10698bbcb31" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityAddressPostalZipCode_9220f2ea-13f0-4b9f-912a-e10698bbcb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_31b0a126-37a4-4693-bbae-2dfcd8698ca8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_CityAreaCode_31b0a126-37a4-4693-bbae-2dfcd8698ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6c19c89b-97a5-48ed-bbd6-65baeda1b966" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_LocalPhoneNumber_6c19c89b-97a5-48ed-bbd6-65baeda1b966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_6a3da47f-8861-4145-9a3c-f79bf7272a83" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_WrittenCommunications_6a3da47f-8861-4145-9a3c-f79bf7272a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_46906c2a-5759-43ba-856c-fdf440714616" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_SolicitingMaterial_46906c2a-5759-43ba-856c-fdf440714616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_64a6fd0f-565d-4ffd-9410-c9b73642a967" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_PreCommencementTenderOffer_64a6fd0f-565d-4ffd-9410-c9b73642a967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4a57ba23-ddea-4256-b91f-06e2dd896d45" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4a57ba23-ddea-4256-b91f-06e2dd896d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_49ae1839-4b40-4465-a798-a3bb6f69b314" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_Security12bTitle_49ae1839-4b40-4465-a798-a3bb6f69b314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_04ee1fc4-bf11-4783-aeb7-68e3ca9493f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_TradingSymbol_04ee1fc4-bf11-4783-aeb7-68e3ca9493f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1cccaaf6-7563-4a32-b0f4-2d217464a9da" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_SecurityExchangeName_1cccaaf6-7563-4a32-b0f4-2d217464a9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d111e11a-d82f-4ec1-903d-e343edea8992" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityEmergingGrowthCompany_d111e11a-d82f-4ec1-903d-e343edea8992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5e95cfe9-b148-4939-87a2-8367ca7f86f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_EntityCentralIndexKey_5e95cfe9-b148-4939-87a2-8367ca7f86f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d1997aab-a87f-4dee-ad0a-e2d74770ceb2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_AmendmentFlag_d1997aab-a87f-4dee-ad0a-e2d74770ceb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_4972ef3b-4705-4cd2-b37b-249a844cb6c6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ddd823e5-42af-4e1f-a4fb-73cedf51a07d" xlink:to="loc_dei_DocumentInformationTable_4972ef3b-4705-4cd2-b37b-249a844cb6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a37ad0f6-1059-4fab-b2e1-44d56c73c34c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_4972ef3b-4705-4cd2-b37b-249a844cb6c6" xlink:to="loc_dei_DocumentInformationLineItems_a37ad0f6-1059-4fab-b2e1-44d56c73c34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0a012402-3b6d-497d-bcc2-157d561f061b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a37ad0f6-1059-4fab-b2e1-44d56c73c34c" xlink:to="loc_dei_DocumentPeriodEndDate_0a012402-3b6d-497d-bcc2-157d561f061b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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MH>UYNX]BG)*%(8JO/F*>8AB@?&5$=6W^7O&F6MFR5VO0K>JKUYAOJ!FW#2I
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E!1CM%$ 'AOLSR6PI>>*)_P/QN*MT\_])Z@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 14, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 14,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Editas Medicine, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4097528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11 Hurley Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">401-9000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EDIT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001650664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 14,  2025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -LXKEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( -LXKEJ>G?G<[P   "L"   1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #;.*Y:'#AEZC\!   \ @  #P
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M=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ VSBN6B0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( -LXKEIED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    " #;.*Y:GIWYW.\    K @  $0
M        @ '#    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #;.*Y:
MF5R<(Q &  "<)P  $P              @ 'A 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( -LXKEK94C^E>00  .81   8              "
M@2((  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #;.*Y:
MGZ ;\+$"  #B#   #0              @ '1#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( -LXKEJ7BKL<P    !,"   +              "  :T/  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( -LXKEH<.&7J/P$  #P"   /
M      "  980  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #;.*Y:)!Z;
MHJT   #X 0  &@              @ $"$@  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " #;.*Y:99!YDAD!  #/ P  $P
M    @ 'G$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   Q
%%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="edit-20250514.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.editasmedicine.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="edit-20250514.htm">edit-20250514.htm</File>
    <File>edit-20250514.xsd</File>
    <File>edit-20250514_def.xml</File>
    <File>edit-20250514_lab.xml</File>
    <File>edit-20250514_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "edit-20250514.htm": {
   "nsprefix": "edit",
   "nsuri": "http://www.editasmedicine.com/20250514",
   "dts": {
    "inline": {
     "local": [
      "edit-20250514.htm"
     ]
    },
    "schema": {
     "local": [
      "edit-20250514.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "edit-20250514_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "edit-20250514_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "edit-20250514_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.editasmedicine.com/role/DocumentandEntityInformation",
     "longName": "0000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20250514.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "edit-20250514.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.editasmedicine.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001650664-25-000081-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001650664-25-000081-xbrl.zip
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MV,6-8/_[6_U[%/-%@;$/2&+>7]]>D>T->.J+&W?&F&E0UE7KMW4;_<8#C_-
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M'3C5M/&^%C?@-W-=>+"E6UW#1)&4U!O&DBDEWYS%S?2]B8" P;_XV 0MR5Z
M#6ZVZQ2=W;W$P]?:CW@/"3W0([P1P&I\3 /2FC O5OR>D>L^^!),_H!N$ZP]
MP<7_<O_H8-+7\[39WWZNND[E1!+% C8>1B$CH?9[LP36-HAQ@0B$W!06T&=U
MLB=[8G)_VXLNVI!S@'I)6)U,H^RL1</'.Z3F+R-@QANDTG+$Z+@0,D*X#?Z;
MO75*=>_[8X]D6-^#X8# P*18!4D>$[$'MNAC6C4<,)]TT=*02RI5LA'R7YQH
MW2GC:@I7]H%_<\B\S[J:E([!&1@+CC%_+YJ0'@NB!UQ=_(B+3JK6;Z3/ ]0
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MWC31Z(4NZMZCT=:#]'#O)U!+ P04    " #;.*Y:A=0ANNL*  "U7   %0
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MU%)!K1748O;,M+P/T^+KR(T32S-.B'3UW N.5J#)L.CJ_C80G:^[H_ AK^I
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M;D3,X[">TDF5"(##>G+'85V ##D-E:$'6O^3C[U*T\!DQ(.VNB=:??FRY>P
M6?""SCT!'@@.F!O!8U_DB>$<,+A+ZM ;1AYGKW^=9[E"<VI&O)1%#"C,(X C
M7M^G36(08\D(3C!+F?4_RNI5F?@@>_T@J+6#S[GO.78K3[:HCG3OA:F[<?\#
M["YCXT^O6U%_SM%UE['><^O.QKY8?E%767TBD%?-#92,24DP#@&K9Z(XCB/
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MP(BKCH.E'$6U\=T:Z@6B_)^ZNFJ6N+A=^/)FGAACP)@G*$VK263$49$(""D
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MF_J0AS*8[?]V(T-AV(68LBL5\NBWFN&1J1NAY=#=:.3?8K^%K*-?I]DBF[U
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M,#(U,#4Q-%]L86(N>&UL4$L! A0#%     @ VSBN6G&;181/!P  CS<  !4
M             ( !O"(  &5D:70M,C R-3 U,31?<')E+GAM;%!+ 0(4 Q0
M   ( -LXKEK/CY]OI P  (=B   >              "  3XJ  !E9&ET87-M
M961I8VEN96%S9V-T:6YV:79O:"YH=&U02P4&      8 !@"3 0  'C<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>edit-20250514_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="edit-20250514.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001650664</identifier>
        </entity>
        <period>
            <startDate>2025-05-14</startDate>
            <endDate>2025-05-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001650664</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-05-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Editas Medicine, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37687</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">46-4097528</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">11 Hurley Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Cambridge,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">02141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">401-9000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">EDIT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
